Polyclonal Antibody to Versican (VCAN)
CSPG2; VS; ERVR; PG-M; WGN1; Chondroitin Sulfate Proteoglycan 2; Chondroitin sulfate proteoglycan core protein 2; Glial hyaluronate-binding; Large fibroblast proteoglycan
- Product No.PAB817Mu01
- Organism SpeciesMus musculus (Mouse) Same name, Different species.
- SourcePolyclonal antibody preparation
- HostRabbit
- Potencyn/a
- Ig Type IgG
- PurificationAntigen-specific affinity chromatography followed by Protein A affinity chromatography
- LabelNone
- Immunogen RPB817Mu01-Recombinant Versican (VCAN)
- Buffer FormulationPBS, pH7.4, containing 0.02% NaN3, 50% glycerol.
- TraitsLiquid
- Concentration0.49mg/ml
- Organism Species Moren/a
- ApplicationsWB
 If the antibody is used in flow cytometry, please check FCM antibodies.
- DownloadInstruction Manual
- UOM 20µl100µl 200µl 1ml 10ml
- FOB
    
                                    US$ 103 
            
                
                        US$ 239 
                                        US$ 342 
                                        US$ 855 
                                        US$ 3420 
                            
 For more details, please contact local distributors!
SPECIFITY
The antibody is a rabbit polyclonal antibody raised against VCAN. It has been selected for its ability to recognize VCAN in immunohistochemical staining and western blotting.
USAGE
        Western blotting: 0.01-2µg/mL
Immunohistochemistry: 5-20µg/mL
Immunocytochemistry: 5-20µg/mL
Optimal working dilutions must be determined by end user.    
STORAGE
Store at 4°C for frequent use. Stored at -20°C in a manual defrost freezer for two year without detectable loss of activity. Avoid repeated freeze-thaw cycles.
STABILITY
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.
GIVEAWAYS
INCREMENT SERVICES
- 
                     Antibody Labeling Customized Service Antibody Labeling Customized Service
- 
                     Protein A/G Purification Column Protein A/G Purification Column
- 
                     Staining Solution for Cells and Tissue Staining Solution for Cells and Tissue
- 
                     Positive Control  for Antibody Positive Control  for Antibody
- 
                     Tissue/Sections Customized Service Tissue/Sections Customized Service
- 
                     Phosphorylated Antibody Customized Service Phosphorylated Antibody Customized Service
- 
                     Western Blot (WB) Experiment Service Western Blot (WB) Experiment Service
- 
                     Immunohistochemistry (IHC) Experiment Service Immunohistochemistry (IHC) Experiment Service
- 
                     Immunocytochemistry (ICC) Experiment Service Immunocytochemistry (ICC) Experiment Service
- 
                     Flow Cytometry (FCM) Experiment Service Flow Cytometry (FCM) Experiment Service
- 
                     Immunoprecipitation (IP) Experiment Service Immunoprecipitation (IP) Experiment Service
- 
                     Immunofluorescence (IF) Experiment Service Immunofluorescence (IF) Experiment Service
- 
                     Buffer Buffer
- 
                     DAB Chromogen Kit DAB Chromogen Kit
- 
                     SABC Kit SABC Kit
- 
                     Long-arm Biotin Labeling Kit Long-arm Biotin Labeling Kit
- 
                     Real Time PCR Experimental Service Real Time PCR Experimental Service
| Magazine | Citations | 
| Plos one | Tumor-Produced Versican V1 Enhances hCAP18/LL-37 Expression in Macrophages through Activation of TLR2 and Vitamin D3 Signaling to Promote Ovarian Cancer Progression In Vitro PubMed: PMC3570526 | 
| Clinica Chimica Acta | Versican and its associated molecules: Potential diagnostic markers for multiple myeloma Pubmed:25623955 | 
| Journal of Cancer Research and Clinical Oncology | Clinical significance of circulatory microRNA-203 in serum as novel potential diagnostic marker for multiple myeloma | 
| RNA Biology | Targeting of stromal versican by miR-144/199 inhibits multiple myeloma by downregulating FAK/STAT3 signaling Pubmed: 31532704 | 
| miR-124-3p and miR-181a-5p Mediate AT1-Receptor Autoantibody Induced Fetal Rat Cardiac Remodeling via Increased VCAN Expression | 
| Catalog No. | Related products for research use of Mus musculus (Mouse) Organism species | Applications (RESEARCH USE ONLY!) | 
| RPB817Mu02 | Recombinant Versican (VCAN) | Positive Control; Immunogen; SDS-PAGE; WB. | 
| RPB817Mu01 | Recombinant Versican (VCAN) | Positive Control; Immunogen; SDS-PAGE; WB. | 
| PAB817Mu01 | Polyclonal Antibody to Versican (VCAN) | WB | 
| PAB817Mu02 | Polyclonal Antibody to Versican (VCAN) | WB; IHC; ICC; IP. | 
| SEB817Mu | ELISA Kit for Versican (VCAN) | Enzyme-linked immunosorbent assay for Antigen Detection. | 
| LMB817Mu | Multiplex Assay Kit for Versican (VCAN) ,etc. by FLIA (Flow Luminescence Immunoassay) | FLIA Kit for Antigen Detection. | 
 
         
 
                             
                             
                            

 
    